Carregant...
Generalization of the time-to-event continual reassessment method to bivariate outcomes
This article considers the problem of designing Phase I-II clinical trials with delayed toxicity and efficacy outcomes. The proposed design is motivated by a Phase I-II study evaluating all-trans retinoic acid (ATRA) in combination with a fixed dose of daratumumab in the treatment of relapsed or ref...
Guardat en:
| Publicat a: | J Biopharm Stat |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6823630/ https://ncbi.nlm.nih.gov/pubmed/31264936 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10543406.2019.1634087 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|